CEACAM8与胃癌患者生存关系的生物信息学分析
Bioinformatics Analysis of the Relationship between CEACAM8 and Survival in Patients with Gastric Cancer
DOI: 10.12677/acm.2025.151009, PDF,   
作者: 孙烨煜：青岛大学青岛医学院，山东 青岛；康复大学青岛中心医院消化内科，山东 青岛；姜艳芳, 李 娜, 李 浩, 贺延新*：康复大学青岛中心医院消化内科，山东 青岛
关键词: 胃癌；CEACAM8；预后；UALCAN；Kaplan-Meier Plotter；Gastric Cancer； CEACAM8； Prognosis； UALCAN； Kaplan-Meier Plotter
摘要: 胃癌在世界范围内直接影响着人类的生活质量，癌胚抗原相关细胞粘附分子(CEACAM)亚家族的一些成员在肿瘤中不受调控。对于CEACAM8在胃癌中的功能知之甚少。为了解决这一问题，本研究使用UALCAN、Kaplan-Meier Plotter、metascape数据库研究了CEACAM8在胃癌预后中的作用。发现CEACAM8的过表达与胃癌患者的临床肿瘤分期和病理肿瘤分级显著相关。此外，CEACAM8 mRNA的高表达与胃癌患者较短的总生存期(OS)显著相关。总的来说，CEACAM8可能是胃癌患者生存的预后生物标志物。
Abstract: Gastric cancer directly affects human quality of life worldwide, and some members of the carcinoembryonic antigen-associated cell adhesion molecule (CEACAM) subfamily are not regulated in tumors. Little is known about the function of CEACAM8 in gastric cancer. In order to solve this problem, this study used UALCAN, Kaplan-Meier Plotter and metascape databases to study the role of CEACAM8 in the prognosis of gastric cancer. It was found that the overexpression of CEACAM8 was significantly correlated with the clinical tumor stage and pathological tumor grade of gastric cancer patients. In addition, high expression of CEACAM8 mRNA was significantly associated with shorter overall survival (OS) in patients with gastric cancer. Overall, CEACAM8 may be a prognostic biomarker for survival in patients with gastric cancer.
文章引用：孙烨煜, 姜艳芳, 李娜, 李浩, 贺延新. CEACAM8与胃癌患者生存关系的生物信息学分析[J]. 临床医学进展, 2025, 15(1): 49-54. https://doi.org/10.12677/acm.2025.151009

参考文献

[1] Nguyen, Q.A., Schmitt, L., Mejías-Luque, R. and Gerhard, M. (2023) Effects of Helicobacter pylori Adhesin HopQ Binding to CEACAM Receptors in the Human Stomach. Frontiers in Immunology, 14, Article 1113478. [Google Scholar] [CrossRef] [PubMed]
[2] Mimura, K., Kua, L., Xiao, J., Asuncion, B.R., Nakayama, Y., Syn, N., et al. (2021) Combined Inhibition of PD-1/PD-L1, Lag-3, and Tim-3 Axes Augments Antitumor Immunity in Gastric Cancer-T Cell Coculture Models. Gastric Cancer, 24, 611-623. [Google Scholar] [CrossRef] [PubMed]
[3] Smyth, E.C., Nilsson, M., Grabsch, H.I., van Grieken, N.C. and Lordick, F. (2020) Gastric Cancer. The Lancet, 396, 635-648. [Google Scholar] [CrossRef] [PubMed]
[4] Taxauer, K., Hamway, Y., Ralser, A., Dietl, A., Mink, K., Vieth, M., et al. (2021) Engagement of CEACAM1 by Helicobacter Pylori HopQ Is Important for the Activation of Non-Canonical NF-κB in Gastric Epithelial Cells. Microorganisms, 9, Article 1748. [Google Scholar] [CrossRef] [PubMed]
[5] Yokoyama, K., Mitoma, H., Kawano, S., Yamauchi, Y., Wang, Q., Ayano, M., et al. (2022) CEACAM1, 3, 5 and 6-Positive Classical Monocytes Correlate with Interstitial Lung Disease in Early Systemic Sclerosis. Frontiers in Immunology, 13, Article 1016914. [Google Scholar] [CrossRef] [PubMed]
[6] Igami, K., Uchiumi, T., Shiota, M., Ueda, S., Tsukahara, S., Akimoto, M., et al. (2022) Extracellular Vesicles Expressing CEACAM Proteins in the Urine of Bladder Cancer Patients. Cancer Science, 113, 3120-3133. [Google Scholar] [CrossRef] [PubMed]
[7] Arias Cardenas, K.C., Enos, C.W., Spear, M.R., Austin, D.E., Almofeez, R., Kortchak, S., et al. (2024) CT109-SN-38, a Novel Antibody-Drug Conjugate with Dual Specificity for CEACAM5 and 6, Elicits Potent Killing of Pancreatic Cancer Cells. Current Cancer Drug Targets, 24, 720-732. [Google Scholar] [CrossRef] [PubMed]
[8] Zhang, X., Han, X., Zuo, P., Zhang, X. and Xu, H. (2020) CEACAM5 Stimulates the Progression of Non-Small-Cell Lung Cancer by Promoting Cell Proliferation and Migration. Journal of International Medical Research, 48. [Google Scholar] [CrossRef] [PubMed]
[9] López, M.J., Carbajal, J., Alfaro, A.L., Saravia, L.G., Zanabria, D., Araujo, J.M., et al. (2023) Characteristics of Gastric Cancer around the World. Critical Reviews in Oncology/Hematology, 181, Article 103841. [Google Scholar] [CrossRef] [PubMed]
[10] Todorova, V.K., Azhar, G., Stone, A., Malapati, S.J., Che, Y., Zhang, W., et al. (2024) Neutrophil Biomarkers Can Predict Cardiotoxicity of Anthracyclines in Breast Cancer. International Journal of Molecular Sciences, 25, Article 9735. [Google Scholar] [CrossRef] [PubMed]
[11] Salvador-Martín, S., Rubbini, G., Vellosillo, P., Zapata-Cobo, P., Velasco, M., Palomino, L.M., et al. (2024) Blood Gene Expression Biomarkers of Response to Anti-TNF Drugs in Pediatric Inflammatory Bowel Diseases before Initiation of Treatment. Biomedicine & Pharmacotherapy, 173, Article 116299. [Google Scholar] [CrossRef] [PubMed]

为你推荐